ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,740Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 517

$1.39M Total Retail Price of All Prescriptions

Rank: 13 out of 517

1,004 Patients Receiving at Least One Drug in Part D
40%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 9,566 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,290 510 1 1
METOPROLOL SUCCINATE 1,008 223 2 21
AMLODIPINE BESYLATE 818 372 3 2
METFORMIN HCL 727 247 4 4
OMEPRAZOLE 710 339 5 3
PROAIR HFA 695 155 6 33
LEVOTHYROXINE SODIUM 649 234 7 6
LISINOPRIL 583 315 8 7
DIOVAN 514 277 9 20
FUROSEMIDE 502 350 10 9
TRAMADOL HCL 405 114 11 19
KLOR-CON 8 398 209 10 12 98
MIRTAZAPINE 350 193 13 95
GABAPENTIN 340 108 14 13
RISPERIDONE 326 56 15 83
JANUVIA 323 235 16 43
PANTOPRAZOLE SODIUM 318 133 17 38
ACTOS 290 148 18 51
METOPROLOL TARTRATE 288 100 19 18
HYDROCHLOROTHIAZIDE 279 124 20 10
ATORVASTATIN CALCIUM 269 114 21 12
HYDROXYZINE PAMOATE 247 35 R 22 268
BENZTROPINE MESYLATE 236 53 R 23 126
VENTOLIN HFA 219 51 24 106
BACLOFEN 218 68 25 91
POTASSIUM CHLORIDE 210 119 26 34
LANTUS 206 124 27 61
TRAZODONE HCL 199 48 28 77
IBUPROFEN 192 50 29 16
DIVALPROEX SODIUM ER 181 0 30 207
TAMSULOSIN HCL 178 133 31 22
GEMFIBROZIL 171 33 32 80
ADVAIR DISKUS 164 48 33 46
FAMOTIDINE 155 82 34 44
TRIHEXYPHENIDYL HCL 154 0 R 35 288
MELOXICAM 152 62 36 25
QUETIAPINE FUMARATE 148 49 37 110
ABILIFY 140 39 38 158
NEXIUM 139 39 39 29
LEVETIRACETAM 133 18 40 143
LOSARTAN POTASSIUM 128 109 41 17
CARVEDILOL 126 92 42 26
LIDODERM 121 90 43 49
BUSPIRONE HCL 120 28 44 121
SERTRALINE HCL 119 33 45 60
FLUOXETINE HCL 117 24 46 87
NAPROXEN 116 39 47 42
DONEPEZIL HCL 116 92 47 28
OLANZAPINE 110 43 49 111
CLOPIDOGREL 108 78 50 47
AMOXICILLIN 106 30 51 58
NAMENDA 101 88 52 52
IBANDRONATE SODIUM 96 66 53 129
COMBIVENT 95 44 54 151
PIOGLITAZONE HCL 94 51 R 55 142
ATENOLOL 94 40 55 8
PROPRANOLOL HCL 94 18 55 112
HALOPERIDOL 93 0 58 212
LACTULOSE 93 63 58 128
CLONIDINE HCL 92 50 60 59
EXELON 89 81 61 152
ALENDRONATE SODIUM 89 77 61 11
DOXYCYCLINE HYCLATE 89 37 61 171
GLIPIZIDE 88 49 64 30
ESCITALOPRAM OXALATE 83 28 65 93
LOVAZA 82 27 66 55
CIPROFLOXACIN HCL 81 48 67 74
SEROQUEL 81 36 67 220
NYSTATIN-TRIAMCINOLONE 81 43 67 272
PHENYTOIN SODIUM EXTENDED 78 19 70 149
METOCLOPRAMIDE HCL 76 51 71 119
CYCLOBENZAPRINE HCL 75 17 R 72 127
BUPROPION XL 75 17 72 215
DIVALPROEX SODIUM 75 26 72 100
TRIAMCINOLONE ACETONIDE 74 34 75 32
BENAZEPRIL HCL 73 37 76 15
FLUOCINONIDE 72 27 77 86
PLAVIX 72 56 77 62
SPIRIVA 71 32 79 84
BONIVA 70 52 80 165
LEVOFLOXACIN 70 39 80 116
LAMOTRIGINE 68 17 82 234
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 22 83 113
SEROQUEL XR 67 0 83 357
DICLOFENAC SODIUM 65 29 85 56
TOPIRAMATE 64 0 86 265
BUMETANIDE 61 37 87 405
SINGULAIR 61 42 87 64
WARFARIN SODIUM 60 44 89 24
LIPITOR 60 29 89 81
CARISOPRODOL 59 23 R 91 66
CYMBALTA 59 24 91 71
PAROXETINE HCL 59 28 91 76
OXYBUTYNIN CHLORIDE 58 20 94 125
PERMETHRIN 58 15 94 413
BUPROPION HCL SR 57 0 96 360
TRICOR 56 0 97 123
DIGOXIN 56 47 97 79
ALLOPURINOL 56 53 97 37
FENOFIBRATE 54 0 100 75
CITALOPRAM HBR 53 12 101 67
VENLAFAXINE HCL ER 53 17 101 195
NIASPAN 53 0 101 154
EXFORGE 51 38 104 158
NIFEDIPINE ER 51 32 104 85
SPIRONOLACTONE 50 37 106 117
TIZANIDINE HCL 50 16 106 367
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.